Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.63 CHF | +1.69% | +7.19% | +6.75% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
Filters
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG